Breast cancer metastases are predominantly osteolytic, driven by tumor-secreted parathyroid hormone-related protein (PTHrP), IL-8, and IL-11, which enhance RANK-L production, stimulating osteoclastogenesis and bone resorption. Here, PTHLH is linked to breast cancer.